|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MOLECULAR AND GENOMIC |
1 Department of Pharmacology, Mailstop 357280, University of Washington, Seattle, WA 98195-7280, USA
Voltage-gated Ca2+ channels of the CaV1 family initiate excitationcontraction coupling in cardiac, smooth, and skeletal muscle and are primary targets for regulation by the sympathetic nervous system in the fight-or-flight response. In the heart, activation of ß-adrenergic receptors greatly increases the L-type Ca2+ current through CaV1.2 channels, which requires phosphorylation by cyclic AMP-dependent protein kinase (PKA) anchored via an A-kinase anchoring protein (AKAP15). Surprisingly, the site of interaction of PKA and AKAP15 lies in the distal C-terminus, which is cleaved from the remainder of the channel by in vivo proteolytic processing. Here we report that the proteolytically cleaved distal C-terminal domain forms a specific molecular complex with the truncated
1 subunit and serves as a potent autoinhibitory domain. Formation of the autoinhibitory complex greatly reduces the coupling efficiency of voltage sensing to channel opening and shifts the voltage dependence of activation to more positive membrane potentials. Ab initio structural modelling and site-directed mutagenesis revealed a binding interaction between a pair of arginine residues in a predicted
-helix in the proximal C-terminal domain and a set of three negatively charged amino acid residues in a predicted helixloophelix bundle in the distal C-terminal domain. Disruption of this interaction by mutation abolished the inhibitory effects of the distal C-terminus on CaV1.2 channel function. These results provide the first functional characterization of this autoinhibitory complex, which may be a major form of the CaV1 family Ca2+ channels in cardiac and skeletal muscle cells, and reveal a unique ion channel regulatory mechanism in which proteolytic processing produces a more effective autoinhibitor of CaV1.2 channel function.
(Received 17 April 2006;
accepted after revision 23 June 2006;
first published online 29 June 2006)
Corresponding author W. A. Catterall: Department of Pharmacology, Mailstop 357280, University of Washington, Seattle, WA 98195-7280, USA. Email: wcatt{at}u.washington.edu
This article has been cited by other articles:
![]() |
A. Singh, M. Gebhart, R. Fritsch, M. J. Sinnegger-Brauns, C. Poggiani, J.-C. Hoda, J. Engel, C. Romanin, J. Striessnig, and A. Koschak Modulation of Voltage- and Ca2+-dependent Gating of CaV1.3 L-type Calcium Channels by Alternative Splicing of a C-terminal Regulatory Domain J. Biol. Chem., July 25, 2008; 283(30): 20733 - 20744. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lyskov and J. J. Gray The RosettaDock server for local protein-protein docking Nucleic Acids Res., July 1, 2008; 36(suppl_2): W233 - W238. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mellstrom, M. Savignac, R. Gomez-Villafuertes, and J. R. Naranjo Ca2+-Operated Transcriptional Networks: Molecular Mechanisms and In Vivo Models Physiol Rev, April 1, 2008; 88(2): 421 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Calin-Jageman, K. Yu, R. A. Hall, L. Mei, and A. Lee Erbin Enhances Voltage-Dependent Facilitation of Cav1.3 Ca2+ Channels through Relief of an Autoinhibitory Domain in the Cav1.3 {alpha}1 Subunit J. Neurosci., February 7, 2007; 27(6): 1374 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Naranjo and B. Mellstrom Split Personality of Transcription Factors Inside and Outside the Nuclear Border Sci. Signal., January 30, 2007; 2007(371): pe5 - pe5. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Hulme, R. E. Westenbroek, T. Scheuer, and W. A. Catterall Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation PNAS, October 31, 2006; 103(44): 16574 - 16579. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |